secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001005286-24-000020
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore receives Nasdaq delisting notice for failure to file FY 2023 10-K and Q1/Q2 10-Qs
--------------------------------------------------------------------------------

- Nasdaq initiated delisting process on Feb 13, 2024 due to non-compliance with Listing Rule 5250(c)(1).
- Company has not filed Form 10-K for FY ended May 28, 2023 nor Q1 and Q2 10-Qs for 2023.
- Company intends to appeal before a Nasdaq Hearing Panel by Feb 20, 2024; hearing automates 15-day stay.
- Hearing typically scheduled 30-45 days after request; no assurance of further stay or compliance before hearing.
- Delinquent filings relate to a previously disclosed restatement for FY 2021, 2022 and other interim periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000020/0001005286-24-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000020/lndc-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer